Learn More
TARGETMOL CHEMICALS INC VX-702 10MG

Supplier: TARGETMOL CHEMICALS INC T251310MG
Also available in 25mg 50mg and bulk. Please contact Fisher for quotes. VX-702 is a highly specific p38α MAPK inhibitor 14-fold higher selectivity for the p38α than p38β. VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases specifically rheumatoid arthritis (RA). purity: 99%
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.